Emerald Clinics Limited (EMD) TRADING HALT SUSPENDED

20mins delayed


1 Year Return

Emerald Clinics Limited Chart

Share price
Market Cap $11.31 million
Today's Movement
Prev. Close
Day Range -
Historical Stats
52w Range -
4w Avg Volume
4w Avg Turnover
Free until 29 Feb

Spreadsheet yet!

Download in Excel or PDF for printing

Data on 1,800+ ASX Companies

  • 12-month Price Targets

  • EPS & Dividends

  • 52w Highs & Lows

It's FREE until 29 February

The BIGGEST ASX Spreadsheet yet! Current Price vs 1 Yr Target Current Price from 52w High Broker Consensus Share Price Data Fundamentals Broker Consensus

EMD Statistics

21 February

1,707 / 2,267

ASX Size Rank

1yr Return

vs Sector (1yr)


vs ASX 200 (1yr)


$11.31 million

Market Cap

Share Issue

83.81 million

All Ords (%)


Short Sold


Current Fundamentals

21 February


PE Ratio

EPS ($)


Earnings Yield


NTA ($)



Dividend Yield

DPS ($)


Gross Div. Yield


Gross DPS ($)


Company Overview

Emerald Clinics Limited (EMD) operates a network of specialist medical clinics (Clinics) and uses purpose-built software and technology to gather high quality clinical data from informed and consenting patients. Emerald is a clinical services and healthcare technology company focused on the provision of care for patients clinically determined to have exhausted conventional therapies and who may be suitable for cannabinoid-based medicines.

Emerald Clinics Limited Logo

Corporate Details

Head Office: North Perth
Managing Director: Michael Winlo
GICS Sub-Industry: Health Care Facilities
Date Listed: 12 Feb 2020
Registry: -
Similar Companies: RHC / SHL / EBO / SNZ / HLS

Upcoming Calendar

Dividend History

Ex-Date Amount Franking Type Payable
No dividends paid in the last 5 years

See Upcoming Dividends for all ASX companies.


Date Heading Pages File Size Time

Broker Consensus

The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.

EMD is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.

Directors & Management

About the Data

Name Title Since Bio
Mr Matthew (Matt) Callahan Non-Executive Director Mar 2018
Dr Stewart James Washer Executive Chairman, Executive Director Mar 2018
Sir John Tooke Non-Executive Director Feb 2020
Dr Michael Winlo Managing Director Nov 2019
Dr Alistair Vickery Executive Director Nov 2018

Director Transactions

About the Data

EMD directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

There are no director transactions for code EMD in our database.

Shareholder Distribution

Shareholder Distribution data is unavailable.

Top 20 Shareholders

About the Data

Name Shares Capital
Stewart James Washer & Patrizia Derna Washer (The Washer Family A/C) 28,400,000 15.44%
Mercator Shipwrights Pty Ltd (Mecator A/C) 19,600,000 10.66%
Mal Washer Nominees Pty Ltd (Mal Washer Family No1 A/C) 19,600,000 10.66%
Mr Craig Lawrence Darby (Craig Lawrence Darby A/C) 19,600,000 10.66%
Gleneagle Asset Management Ltd (Alium Alpha Fund A/C) 7,000,000 3.81%
Mr Stephen Peter Somerville 4,900,000 2.66%
Mr Jackie Au Yeung 3,625,000 1.97%
Mr Pak Lim Kong 3,416,667 1.86%
J P Morgan Nominees Australia Pty Limited 2,900,000 1.58%
CB1 Wellness Master Fund LP 2,200,000 1.20%
Blue Lake Partners Pty Ltd 2,000,000 1.09%
Adam James (Araucaria A/C) 1,960,000 1.07%
D Schecter Medicine Professional Corporation 1,960,000 1.07%
Ceres Capital Pty Ltd 1,875,000 1.02%
Lakewest Pty Ltd (Raymond Desmond Family A/C) 1,750,000 0.95%
CS Fourth Nominees Pty Limited (HSBC Cust Nom Au Ltd 11 A/C) 1,675,000 0.91%
Canopy Growth Corporation 1,562,500 0.85%
Cann Group Limited 1,562,500 0.85%
HSBC Custody Nominees (Australia) Limited 1,562,500 0.85%
Page Girl Pty Ltd (The Miegunyah A/C) 1,250,000 0.68%
All other shareholders 30.16 %

The Top 20 Shareholders of EMD hold 69.84% of shares on issue.

EMD Share Price History

Date Close Change % Change Open High Low Volume Turnover

EMD Historical Data

Download up to 20 years of share price history.

Year Closing Price (30 June) Last Trade

Offical data as published by ASX. See more Data Downloads.

Company Details

Principal Activity: Operates a network of specialist medical clinics and uses purpose built software and technology to gather clinical data from consenting patients. The anonymised data is commercialised as clinical evidence.

Incorporated: --

Level 1, 50 Angove St
North Perth WA 6006

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.